Crossmark

Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target

Crossref DOI link: https://doi.org/10.1007/s00726-021-02999-5

Published Online: 2021-05-18

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bogner, Alexandra N. https://orcid.org/0000-0002-0358-422X
Stiers, Kyle M. https://orcid.org/0000-0001-5542-022X
Tanner, John J. https://orcid.org/0000-0001-8314-113X
Funding

Funding for this research was provided by:

National Institute of General Medical Sciences (R01GM132640)
License Information

Text and Data Mining valid from 2021-05-18

Version of Record valid from 2021-05-18
More Information

Article History

Received: 19 March 2021

Accepted: 4 May 2021

First Online: 18 May 2021

Declarations

:

: The authors declare that they have no conflict of interest.

: This is a review article and does not involve any human participants or animal work.

: The article is a review article, there are no human participants involved.

Document is current

Any future updates will be listed below